Jewel Patch Wearable Cardioverter Defibrillator (P-WCD) (Jewel) vs Ligence Heart

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

AI Verdict

Tool A (Jewel Patch WCD) is a wearable device focused on continuous heart monitoring and therapeutic intervention for life-threatening arrhythmias. In contrast, Tool B (Ligence Heart) is a software platform designed to automate the analysis and reporting of echocardiography images for diagnostic efficiency. While both utilize AI in cardiology, they are not direct competitors as they address distinct aspects of cardiac care: real-time patient management and therapy versus diagnostic imaging workflow enhancement.

Choose Jewel Patch Wearable Cardioverter Defibrillator (P-WCD) (Jewel) if…

Choose the Jewel Patch Wearable Cardioverter Defibrillator if your patient requires continuous, discreet monitoring for life-threatening arrhythmias and immediate defibrillation capabilities outside of a hospital setting. This device is ideal for individuals needing high patient compliance due to its water-resistant, patch-based design that can be worn continuously.

View Jewel Patch Wearable Cardioverter Defibrillator (P-WCD) (Jewel) →

Choose Ligence Heart if…

Choose Ligence Heart if your cardiology department aims to significantly enhance the efficiency and accuracy of 2D transthoracic echocardiography analysis and reporting. This AI-powered platform is best suited for clinics and hospitals looking to automate measurements, classify views, and generate comprehensive reports, integrating seamlessly with existing PACS and EHR systems.

View Ligence Heart →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Jewel Patch Wearable Cardioverter Defibrillator (P-WCD) (Jewel) Ligence Heart
Pricing Unknown Contact-for-pricing
Deployment Wearable device with mobile app Cloud-based; on-premise; hybrid
BAA Available Unknown Yes AI-estimated
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Jewel Patch Wearable Cardioverter Defibrillator (P-WCD) (Jewel)

The Jewel Patch WCD demonstrates strong patient usability with a median wear time of over 23 hours per day, indicating high compliance due to its comfortable, discreet, and water-resistant design. This directly addresses a critical challenge in wearable defibrillators, allowing patients to integrate the device seamlessly into daily activities like showering and exercise.

Clinical Value

Jewel Patch Wearable Cardioverter Defibrillator (P-WCD) (Jewel)

The Jewel P-WCD offers direct therapeutic intervention by continuously monitoring and treating life-threatening arrhythmias, successfully converting ventricular tachycardia or fibrillation events and preventing sudden cardiac arrest. Clinical studies have confirmed its safety and effectiveness, reporting no deaths in enrolled patients and a very low inappropriate shock rate.

Pricing & Value

Tie

Both tools employ a 'contact vendor for pricing' model with no publicly available pricing details, making it impossible to conduct a meaningful head-to-head comparison of their value propositions. While Ligence Heart mentions a 'one-time license fee based on number of installations,' specific costs remain undisclosed.

Enterprise Readiness

Ligence Heart

Ligence Heart explicitly offers robust integration capabilities with existing hospital systems such as PACS, EHR, and RIS, and provides flexible deployment options including cloud-based, on-premise, and hybrid solutions. This comprehensive approach to integration and deployment demonstrates a higher level of readiness for diverse enterprise environments compared to Tool A's focus on its own digital health platforms.

Innovation

Jewel Patch Wearable Cardioverter Defibrillator (P-WCD) (Jewel)

The Jewel P-WCD represents a significant innovation with its discreet, water-resistant, patch-based design that enables high patient compliance (over 23 hours/day), addressing a critical limitation of traditional wearable cardioverter defibrillators. This patient-centric design for a life-saving device is a revolutionary advancement in its field.

Support & Docs

Jewel Patch Wearable Cardioverter Defibrillator (P-WCD) (Jewel)

Element Science provides comprehensive product manuals, instructional videos, and explicitly states 24/7 customer service availability via phone and email for the Jewel P-WCD. This round-the-clock support for a life-saving device offers a higher level of assurance and accessibility compared to the documented support for Ligence Heart.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Jewel Patch Wearable Cardioverter Defibrillator (P-WCD) (Jewel) Ligence Heart
Name Jewel Patch Wearable Cardioverter Defibrillator (P-WCD) (Jewel) Ligence Heart
Company Element Science, Inc. Ligence
Primary Use Case / Function Continuous heart monitoring and treatment of life-threatening arrhythmias. Automates the analysis and reporting of 2D transthoracic echocardiography.
Key Technological Approach Machine learning detection algorithm for arrhythmia detection AI-powered web-based platform
Specific Feature: Continuous Wear / Water Resistance Water-resistant design for continuous wear, including showering; High patient compliance (median wear time over 23 hours/day) Not specified
Specific Feature: Automated Analysis / Reporting Not specified Automated recognition of echocardiography imaging data, view classification and heart phase prediction, calculation of measurements and report generation.

Videos

Demos, reviews, and walkthroughs featuring Jewel Patch Wearable Cardioverter Defibrillator (P-WCD) (Jewel) and Ligence Heart.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

The Jewel Patch Wearable Cardioverter Defibrillator (P-WCD) is a hardware device designed for continuous heart monitoring and treatment of life-threatening arrhythmias, targeting patients requiring such intervention. Ligence Heart is an AI-powered web-based platform that automates the analysis and reporting of 2D transthoracic echocardiography, primarily assisting cardiologists and sonographers in diagnostic efficiency and accuracy.
The Jewel Patch WCD utilizes an associated Jewel Mobile App and cloud-based digital health platform to provide near real-time therapy information to the medical team. Ligence Heart is designed for integration with existing systems such as PACS, EHR, and RIS, and transfers echocardiography images with PHI removed for analysis.
The Jewel Patch WCD performs continuous heart rhythm monitoring and uses a machine learning algorithm for arrhythmia detection. Ligence Heart automates the recognition and analysis of 2D transthoracic echocardiography imaging data, including view classification, heart phase prediction, and various measurements.
The Jewel Patch WCD offers benefits such as high patient compliance due to its water-resistant and discreet design, continuous wear, and the ability to detect and treat life-threatening arrhythmias. Ligence Heart enhances diagnostic efficiency and accuracy for cardiologists and sonographers through automated echocardiography analysis, measurement calculations, and disease recognition.
AI Tool Finder
AI-powered search. Results may not be comprehensive.